Hypotrichosis is a condition marked by a reduced amount of hair on the head and/or body. Specifically, Hypotrichosis of the eyelashes is described as inadequate, thin eyelashes, or not enough eyelashes. Those suffering from hypotrichosis complain of having short, intermittent lashes.
Many eyelash conditioners and enhancers have become available to the public, promising longer, thicker lashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes. LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile applicator.
A: LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
A: Hypotrichosis is another name for having inadequate or not enough eyelashes.
A: LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase; and second, it increases the number of hairs in this growth phase. The exact way it works is unknown.
A: LATISSE® solution is a once-a-day treatment you apply yourself each evening to the base of the upper eyelashes. DO NOT APPLY in your eye or to the lower lid because excess hair growth outside the treatment area may occur. See the full instructions in How to Apply.
A: LATISSE® users may start to see longer lashes at 4 weeks, with full growth at 16 weeks.
A: No, LATISSE® does not work in place of mascara. LATISSE® is a solution treatment for inadequate or not enough lashes and requires a prescription from a doctor. However, mascara can be used on your eyelashes in addition to LATISSE®.
A: LATISSE® solution is the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes, growing them longer, fuller and darker.
A: If you miss an application, or a few, don’t try to catch up. Just apply the LATISSE® treatment the next evening and stay on schedule.
A: If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.
A: Contact lenses should be removed prior to application of LATISSE® and may be reinserted 15 minutes following its administration.
A: Do not use LATISSE® solution if you are allergic to one of its ingredients.
A: Active ingredient: bimatoprost Inactive ingredients: benzalkonium chloride; sodium chloride; sodium phosphate, dibasic; citric acid; and purified water. Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life ranges from 6.8 — 7.8.
A: Increased brown iris pigmentation has occurred when the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure. Although iris pigmentation was not reported in clinical studies with LATISSE®, patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent.